Skip to main content
TEVA $42.62 +0.12%
TEVA logo
TEVA · Teva Pharmaceutical Industries Ltd
Track TEVA — free
$42.62 +0.05 (+0.12%) At close · Nov 17 Play latest call Q3 2026 earnings call transcript
Market Cap
$49.73B
Shares
1.17B
Volume · Nov 17 7.02M Avg daily vol (3M) 6.16M
All webcasts

Earnings call · FY2020 Q3

Teva Pharmaceutical Industries Ltd (TEVA) Q3 2020 Earnings Call

Concluded Nov 5, 2020
Nov 5, 2020
Period
FY2020 Q3
Runtime
—
Sources
2 artifacts
Revenue $3.98B -2.8% YoY
Diluted EPS -$3.97
Gross margin 46.6% +1.9 pp YoY
Net income -$4.35B
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

North America Segment$2.02B -1.7% YoY
Europe Segment$1.12B -4% YoY
International Markets$529.00M -6.4% YoY
Other Activities$316.00M +0.6% YoY
Full-screen source Call document